AskVantage

Biotech and enhanced humans

Scientists are starting to classify ageing as a disease

By treating age as a disease, not as an inevitable condition, it forces researchers to look at the problem differently and come up with new, unexpected solutions

Key takeaways

  • While the notion might at first seem out there and implausible there are two arguments here.
  • British biologist Aubrey de Grey argues that, just like diseases, the symptoms of ageing all have a solution.
  • In 2012 they identified two types of bacteria that release enzymes capable of effectively and completely breaking down 7-ketocholesterol (7KC), a substance responsible for cardiovascular disease.
Cite or link to this article

Griffin, M. (2016) 'Scientists are starting to classify ageing as a disease', 311 Institute, 16 December. Available at: https://www.311institute.com/scientists-are-starting-to-classifying-ageing-as-a-disease/ (Accessed: 1 October 2026).

Many diseases come with old age but the idea of pathologizing ageing itself has been gaining attention the past few years. Some argue that ageing is just damage that the body has sustained throughout its lifetime and that these natural wear and tear effects can be stopped and ultimately undone.

While the notion might at first seem out there and implausible there are two arguments here. Firstly, we have an increasing body of evidence that seems to show that ageing is the result of damage to, among other things, our cells and genes. Secondly by re-framing age as a disease it forces people to look at the problem in a different way and it pushes us to invent and examine new solutions.

British biologist Aubrey de Grey argues that, just like diseases, the symptoms of ageing all have a solution. We just either haven’t found or perfected them yet.

He says that ageing is the result of the accumulation of “garbage material” that our cells cannot break down. De Grey and his team decided to look into the phase after death for a solution to sustaining life and youth - decomposition. They hypothesized that the answer lies in the decomposition of dead bodies, where there are bacteria that can break down everything in the human body, including those our bodies could not break down on their own while we are alive.

And it worked. In 2012 they identified two types of bacteria that release enzymes capable of effectively and completely breaking down 7-ketocholesterol (7KC), a substance responsible for cardiovascular disease. They then modified the genes of these bacteria so that they would work within human cells, which were then successfully protected from the toxic substance.

But that’s just one example, there are many others.

The changing perspective on ageing is yielding different approaches to diseases common with age. More scientists are beginning to share this view and more medical research is being focused on undoing damage and identifying deficiencies rather than merely alleviating symptoms.

In a recent trial, for example, researchers transfused blood plasma from young people into elderly Alzheimer’s patients after lab tests on mice showed promising results in old mice where the method helped to dramatically improve both their physical and mental performance.

Mutaz Musa, physician at the Department of Emergency Medicine at Albert Einstein College of Medicine, says that whether to pathologize ageing or not seems to be “largely semantic,” but he agrees that it should be perceived and treated as a disease.

“Although many of de Grey’s claims remain controversial - notably, that the first person who will live to 1,000 years old is already among us - I agree that we can and should pathologize ageing. In fact, it seems we already have,” he said.

Either way, whether we try to treat it as a disease or just treat it for what it is, the fact is that slowly, piece by piece, scientists are slowly unravelling the mysteries of ageing.

FAQ

Why does this matter?

By treating age as a disease, not as an inevitable condition, it forces researchers to look at the problem differently and come up with new, unexpected solutions

Matthew Griffin

About the author

Matthew Griffin Founder, 311 Institute

Matthew Griffin is a multi-award winning Futurist and expert in Disruption and Innovation, Geopolitics, Leadership, and Technology, who NASA have described as a "walking encyclopaedia of the future" and a "futurist Polymath."

Read full bio

Matthew Griffin is a multi-award winning Futurist and expert in Disruption and Innovation, Geopolitics, Leadership, and Technology, who NASA have described as a "walking encyclopaedia of the future" and a "futurist Polymath." 15-time best selling author of the "Codex of the Future" series, Matthew is the Founder and Futurist in Chief of the 311 Institute, a global Futures and Deep Futures advisory firm working with royal households, world leaders, G7, G20, and G77 governments, NGOs, and multi-national mid and mega cap firms to help them explore, shape, and lead the next 50 years of business and society.

An award-winning YouTube creator with over a million followers, with an unrivalled global reach and impact, Matthew is a highly sought-after international keynote speaker, lecturer, and mentor who collaborates with global leaders through the United Nations Alliance of Civilizations (UNAOC) and United Nations General Assembly (UNGA) to shape pivotal initiatives such as the UN’s AI for Humanity program, the United Nations Conference of the Parties (UN COP), and the World Economic Forum in Davos.

As the former Global Head of Cloud, National Security, and Enterprise Sales for companies including Atos, Dell-EMC, and IBM, Matthew has a proven track record of building multi-billion dollar business units and turning failing divisions into market leaders. His ability to identify, analyse, and communicate the implications of hundreds of emerging technologies and trends is unparalleled, and his insights are trusted by many of the world’s most respected organisations, including ABB, Accenture, Adidas, AON, ARM, BCG, Centrica, Citi, Coca-Cola, Dentons, Deloitte, Dow Jones, EY, Google, KPMG, Lego, Legal & General, LinkedIn, Microsoft, PepsiCo, Qualcomm, RWE, Samsung, Siemens AG and Siemens Energy, T-Mobile, UBS, VISA, Walmart, Workday, Worldpay and many others.

Regularly featured in the global media including the AP, BBC, Bloomberg, CNBC, Discovery, Forbes, Khaleej Times, Telegraph, TIME, ViacomCBS, WIRED, and the WSJ, Matthews mission is to help organisations create a fair and sustainable future whose benefits are shared by everyone irrespective of their ability, background, or circumstances.

What future do you need to see?

Choose one to get started on biotech and enhanced humans and the future of your organisation.

Where should Matthew reply?

Takes 30 seconds. No obligation. Matthew replies quickly. Privacy

Tag Cloud

Sources and further reading

  1. 7-ketocholesterol ncbi.nlm.nih.gov
  2. Albert Einstein College of Medicine einstein.yu.edu

Source: first published by the 311 Institute on 16 December 2016. Cite as: Griffin, M. (2016). Scientists are starting to classify ageing as a disease. 311 Institute. https://www.311institute.com/scientists-are-starting-to-classifying-ageing-as-a-disease/

You are welcome to quote this article with credit and a link to the original.

Book a Keynote